PET study of D1 dopamine receptor binding in neuroleptic-naive patients with schizophrenia

American Journal of Psychiatry

Volumn 159, Issue 5, 2002, Pages 761-767

  Karlsson, Per ^a   Farde, Lars ^a   Halldin, Christer ^a   Sedvall, Göran ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; CARBON 11; DOPAMINE 1 RECEPTOR; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRAIN ASYMMETRY; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; HUMAN; MALE; NEOCORTEX; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RATING SCALE; RECEPTOR BINDING; RECEPTOR DENSITY; SCATCHARD PLOT; SCHIZOPHRENIA;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ADULT; ANTIPSYCHOTIC AGENTS; BRAIN; BRIEF PSYCHIATRIC RATING SCALE; CARBON RADIOISOTOPES; CAUDATE NUCLEUS; CEREBRAL CORTEX; FEMALE; FRONTAL LOBE; HUMANS; MALE; PSYCHOTIC DISORDERS; PUTAMEN; RECEPTORS, DOPAMINE D1; SCHIZOPHRENIA; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036242723     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.159.5.761     Document Type: Article

References (53)

1. The significance of dopamine receptor blockade for the mechanism of action of neuroleptic drugs
2. Dopamine D3 receptor: Basic and clinical aspects
3. Dopamine receptor pharmacology
4. Update on dopamine receptors
5. Brain imaging of schizophrenia - The dopamine hypothesis
6. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain
7. Molecular biology of dopamine receptors
8. Novel dopamine receptors half a decade later
9. Dopamine receptors: From structure to function
10. Dopamine receptor mRNA expression in human striaturn and neocortex
11. The human dopamine D5 receptor gene: Cloning and characterization of the 5′-flanking and promoter region
12. Dopamine, the prefrontal cortex and schizophrenia
13. The dopamine hypothesis of schizophrenia: Current status, future prospects
14. Dopamine receptor subtype imbalance in schizophrenia
15. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases
16. Binding of [11C]SCH 23390 to post-mortem brain tissue in schizophrenia
17. Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients
18. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain
19. Working memory and the mind
20. D1 dopamine receptors in prefrontal cortex: Involvement in working memory
21. The role of D1-dopamine receptor in working memory: Local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task
22. Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation
23. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex
24. Working memory dysfunction in schizophrenia
25. Spatial working memory deficits in the relatives of schizophrenic patients
26. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems
27. Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography
28. Dopamine D1-receptor binding in the living human brain
29. PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride
30. Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans - A PET study with [11C]SCH 23390 and [11C]raclopride
31. Oral administration of NNC 756-a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man
32. Reproducibility of the distribution of carbon-11-SCH 23390, a dopamine D1 receptor tracer, in normal subjects
33. Dopamine receptor radioligands
34. D1 dopamine receptor binding in drug naive schizophrenic patients measured by PET
35. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET
36. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography
37. Effects of lorazepam administration on striatal dopamine D2 receptor binding characteristics in man - A positron emission tomography study
38. The brief psychiatric rating scale
39. Mini-compendium of rating scales for states of anxiety depression mania schizophrenia with corresponding DSM-III syndromes
40. Head fixation device for reproducible position alignment in transmission CT and positron emission tomography
41. Evaluation of the Karolinska new positron camera system: The Scanditronix PC2048-15B
42. Human dopamine receptor subtypes-in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride
43. Dopamine receptors in human brain: Autoradiographic distribution of D1 sites
44. 11C]raclopride binding to D2-dopamine receptors studied by PET-a comparison to the equilibrium analysis
45. 11C]raclopride binding
46. Age-dependent decline of dopamine D1 receptors in human brain: A PET study
47. Developmental regulation of the dopamine D1 receptor in human caudate and putamen
48. 11C]SCH 23390: A test-retest analysis
49. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756
50. A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain
51. Carbon-11-NNCNNC 112: A radioligand for PET examination of striatal and neocortical D1-dopamine receptors
52. Measurement of striatal and extrastriatal dopamine D-1 receptor binding potential with [C-11]NNC) 112 in humans: Validation and reproducibility